Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck

Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck

Abstract Background Recent studies have suggested a correlation between ABO blood type and the effectiveness of immune checkpoint inhibitors. However, the relationship between ABO blood type and response to pembrolizumab monotherapy as first-line treatment for squamous cell carcinoma of the head and...

Full description

Saved in:
Bibliographic Details
Main Authors: Shogen Boku, Tatsuki Ikoma, Tomoyo Yasuda, Nobuhiro Shibata, Tomofumi Sakagami, Kensuke Suzuki, Takuo Fujisawa, Hiroshi Iwai, Masashi Kanai
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
Pembrolizumab
Immune checkpoint inhibitor
Head and neck cancer
ABO blood type
Online Access:https://doi.org/10.1007/s12672-025-03105-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-03105-x

Similar Items